Please login to the form below

Not currently logged in
Email:
Password:

Stephen Eck joins Aravive Biologics

He takes up president and CEO positions

Aravive Biologics has appointed Stephen Eck as its new CEO and president at a time when the company is preparing to advance its lead drug candidate Aravive-S6 into human clinical testing.

Eck has served a number of global pharmaceutical companies in senior roles, including Eli Lilly and Pfizer, and most recently at Astellas Pharma as vice president of oncology medical sciences.

He said: “I am very excited to be joining Aravive at this point in the company’s development.

"I look forward to helping Aravive realise the full potential that I believe Gas6/AXL inhibition can bring to the treatment of cancer.”

Eck also serves on the board of directors of Texas-based life sciences company Luminex Corporation, he is a fellow of the American Association for the Advancement of Science and is chairman of the board of directors of the Personalised Medicine Coalition.

Ray Tabibiazar, founding president and CEO of Aravive, said: “Stephen has an impressive track-record of oncology drug and biomarker development at prominent pharmaceutical companies, as well as a close relationship to Houston’s M.D Anderson Cancer Centre as a member of the Advisory Board for their oncology Moonshot Programme.

“We welcome his expertise and leadership to the Aravive team.”

Eck succeeds Ray Tabibiazar who will remain as chairman of the company’s board of directors.

12th May 2017

From: Sales

Share

Tags

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Tree
Pharma’s vital role in sustainability and corporate social responsibility
Pharma is in the spotlight as tough questions about sustainability commitments continue to arise...
Infographic: Therapy Watch Hyperlipidaemia
Our latest infographic offers an introduction to the real-world insights collected by our Hyperlipidaemia study....
Article: The rise of the healthcare influencer
In our latest article for Pharmaphorum Deep Dive, we explore the opportunities and benefits for healthcare companies in the online influencer space....